Alzheimer’s disease and mild cognitive impairment
Government announces £375 million investment in neurodegenerative conditions research
On Sunday (14th November) the government announced £375 million of investment over the next five years to fund projects to improve our understanding and treatment of a range of neurodegenerative conditions, including Motor Neurone Disease (MND), Parkinson’s disease dementia and Lewy’s Body dementia. The announcement comes after the success of the United to End MND […]